Ces Urol 2001, 5(2):38-40 | DOI: 10.48095/cccu2001019
Prostatitis mycotica
- 1 Urocentrum Praha
- 2 Cotraxim, mikrobiologická laboratoř, s.r.o.
Chronic inflammations of prostate are crux urologicum. In comparison to other prostatic diseases (benign prostatic hyperplasia, prostatic carcinoma) they require significantly more follow-ups. The cultivation of pathogenic agents is in cca 80 % unsuccessful and only symptomatic treatment is available. Aim of this work is to show the less usual pathogens that can cause the inflammation.
On a case of three men with longtime symptoms we document the diagnostic and treatment options in mycotic prostatitis. The first line drug is fluconazolum.
Mycotic prostatitis is a severe systemic illness. Untreated complicated inflammation influences the life quality and can result in life threatening candidemia.
Keywords: Prostatitis, AAycotic infections, Fluconazolum
Published: March 1, 2001
References
- Holmberg K, Meyer RD: Diagnosis and therapy of systemic fungal infection. Raven Press, 1989, 212 s.
- Háber J, Klener P: Amphotericin B a 5-flucytosin v léčbě systémových mykóz. Remedia, 2, 1992, č. 6, s. 301 - 305.
- Háber J: Fluconazolum. Remedia, 2, 1992, č. 4-5, s. 209 - 216.
- Háber J: Itraconazolum. Remedia, 3, 1993, č. 6, s. 329 - 336.
- Matoušková M: Mykotické infekce v urologické praxi. Sestra, 7, 1997, č. 3, tématický sešit 14.
- Walsh TJ, Pizzo PA: Laboratory diagnosis of candidiasis. In: Bodey, GP: Candidiasis. Pathogenesis, diagnosis and treatment. Raven Press, 1993, s. 110 - 135.